Belimumab

Red

Brand Name(s):Benlysta

Indication:SLE – Active autoantibody-positive with a high degree of disease activity. (add-on therapy for patients aged over 5)

Rationale:1,2

Considered:Jul-11

Review Date:Jan-25

Comments:
Drug Safety Update
Belimumab : increased risk of serious psychiatric events seen in clinical trials
April 2019
…………………………
NICE TA 397 Belimumab for treating active autoantibody-positive systemic lupus erythematosus
June 2016